OMED Stock Ownership Activity
ONCOMED PHARMACEUTICALS INC 13F holders
No value investing guru has made any change to the ONCOMED PHARMACEUTICALS INC (OMED) position according to the gurus' latest SEC quarterly report(s).
Which gurus or hedge funds are buying OMED now?
According to the latest SEC filing(s) ONCOMED PHARMACEUTICALS INC (OMED) has not been purchased by any super investor.
To see more about who is investing in ONCOMED PHARMACEUTICALS INC (OMED), please go to the OMED ownership page.
2018 Q3
(1 result)
Reported price*: $2.31
2018 Q2
(1 result)
Reported price*: $2.31
2018 Q1
(1 result)
Reported price*: $3.18
2017 Q4
(1 result)
Reported price*: $4.10
2017 Q3
(1 result)
Reported price*: $4.52
2017 Q2
(1 result)
Reported price*: $3.33
2017 Q1
(1 result)
Reported price*: $9.21
2016 Q4
(1 result)
Reported price*: $7.71
2016 Q3
(1 result)
Reported price*: $11.43
2016 Q2
(1 result)
Reported price*: $12.31
2016 Q1
(1 result)
Reported price*: $10.11
2015 Q4
(1 result)
Reported price*: $22.54
2015 Q3
(1 result)
Reported price*: $16.59
13 of 13
Shares, change to shares, sold shares - split-adjusted.
Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.
Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.